Showing 1 - 4 results of 4 for search 'Stefan Holdenrieder', query time: 0.04s Refine Results
  1. 1
    Clinical and laboratory considerations: determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19

    Clinical and laboratory considerations: determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19 by Stefan Holdenrieder, Carlos Eduardo Dos Santos Ferreira, Jacques Izopet, Elitza S. Theel, Andreas Wieser, Andreas Wieser, Andreas Wieser, Andreas Wieser

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Individualized versus Standardized Risk Assessment in Patients at High Risk for Adverse Drug Reactions (The IDrug Randomized Controlled Trial)-Never Change a Running System?

    Individualized versus Standardized Risk Assessment in Patients at High Risk for Adverse Drug Reactions (The IDrug Randomized Controlled Trial)-Never Change a Running System? by Katja S. Just, Catharina Scholl, Miriam Boehme, Kathrin Kastenmüller, Johannes M. Just, Markus Bleckwenn, Stefan Holdenrieder, Florian Meier, Klaus Weckbecker, Julia C. Stingl

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    A prognostic baseline blood biomarker and tumor growth kinetics integrated model in paclitaxel/platinum treated advanced non‐small cell lung cancer patients

    A prognostic baseline blood biomarker and tumor growth kinetics integrated model in paclitaxel/platinum treated advanced non‐small cell lung cancer patients by Francis Williams Ojara, Andrea Henrich, Nicolas Frances, Yomna M. Nassar, Wilhelm Huisinga, Niklas Hartung, Kimberly Geiger, Stefan Holdenrieder, Markus Joerger, Charlotte Kloft

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Phenprocoumon Dose Requirements, Dose Stability and Time in Therapeutic Range in Elderly Patients With CYP2C9 and VKORC1 Polymorphisms

    Phenprocoumon Dose Requirements, Dose Stability and Time in Therapeutic Range in Elderly Patients With CYP2C9 and VKORC1 Polymorphisms by Katharina Luise Schneider, Katharina Luise Schneider, Melanie Kunst, Ann-Kristin Leuchs, Miriam Böhme, Klaus Weckbecker, Kathrin Kastenmüller, Markus Bleckwenn, Stefan Holdenrieder, Christoph Coch, Gunther Hartmann, Julia Carolin Stingl, Julia Carolin Stingl

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: